![](https://www.diabetesnews.com/wp-content/uploads/2013/11/green-eye-150x150.jpg)
People with type 2 diabetes who intensively controlled their blood sugar level during the landmark ACCORD Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy.